Weighing The Costs: Obesity Drug Users Make Financial Sacrifices As Coverage Tightens

Vacations are on hold, dinners out skipped, and doses stretched, all so patients can keep taking weight-loss drugs like Wegovy and Zepbound as insurers pull back coverage in 2025.

Physicians say insurance coverage is more limited this year, according to Reuters. As a result, many employers are removing the costly drugs from benefit plans.

These GLP-1 drugs, administered weekly, carry U.S. insurer list prices exceeding $1,000 monthly.

Also Read: Hims & Hers Remains Outside Novo Nordisk’s Growing Legal Storm For Now

Csh-paying customers can obtain them directly from drugmakers for $499 a month under certain purchase conditions. But that still represents a significant expense for most households.

Doctors emphasize that patients taking these medications are also advised to follow proper diet and exercise routines.

However, clinical trials indicate that ...